Carmine Circelli is an experienced board member and investment professional with a focus on life sciences. Currently serving as a board member at Curve Therapeutics, Microbiotica, and Perspectum Ltd since early 2023, and a director at British Patient Capital since January 2021, Carmine has held various roles in investment management, including senior investment manager and investment associate at established firms such as Mercia Asset Management PLC and the Development Bank of Wales. Carmine's academic background includes a PhD in Cardiac Physiology and a BSc (Hons) in Pharmacology from The University of Manchester, complemented by earlier experience in commercialization and sales.